Kanada - francouzština - Health Canada

bayer healthcare llc - facteur antihémophilique (recombiné) - poudre pour solution - 250unité - facteur antihémophilique (recombiné) 250unité - hemostatics

Kanada - francouzština - Health Canada

bayer healthcare llc - facteur antihémophilique (recombiné) - poudre pour solution - 500unité - facteur antihémophilique (recombiné) 500unité - hemostatics

Kanada - francouzština - Health Canada

bayer healthcare llc - facteur antihémophilique (recombiné) - poudre pour solution - 1000unité - facteur antihémophilique (recombiné) 1000unité - hemostatics

Kanada - francouzština - Health Canada

bayer healthcare llc - facteur antihémophilique (recombiné) - poudre pour solution - 2000unité - facteur antihémophilique (recombiné) 2000unité - hemostatics

Kanada - francouzština - Health Canada

bayer healthcare llc - facteur antihémophilique (recombiné) - poudre pour solution - 3000unité - facteur antihémophilique (recombiné) 3000unité - hemostatics

Spojené státy - angličtina - NLM (National Library of Medicine)

bayer healthcare, llc animal health division - florfenicol (unii: 9j97307y1h) (florfenicol - unii:9j97307y1h) - florfenicol 300 mg in 1 ml - loncor™ 300 is indicated for treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica , pasteurella multocida , and histophilus somni , and for the treatment of bovine interdigital phlegmon (foot rot, acute interdigital necrobacillosis, infectious pododermatitis) associated with fusobacterium necrophorum and bacteroides melaninogenicus . also, it is indicated for the control of respiratory disease in cattle at high risk of developing brd associated with mannheimia haemolytica , pasteurella multocida , and histophilus somni . do not use in animals that have shown hypersensitivity to florfenicol. this product contains materials that can be irritating to skin and eyes. avoid direct contact with skin, eyes, and clothing. in case of accidental eye exposure, flush with water for 15 minutes. in case of accidental skin exposure, wash with soap and water. remove contaminated clothing. consult a physician if irritation persists. accidental injection of this product may cause local irritatio

Spojené státy - angličtina - NLM (National Library of Medicine)

bayer healthcare llc animal health division - praziquantel (unii: 6490c9u457) (praziquantel - unii:6490c9u457), pyrantel pamoate (unii: 81bk194z5m) (pyrantel - unii:4qih0n49e7), febantel (unii: s75c401os1) (febantel - unii:s75c401os1) - praziquantel 22.7 mg - drontal® plus (praziquantel/pyrantel pamoate/febantel) broad spectrum anthelmintic tablets are indicated for removal of tapeworms (dipylidium caninum, taenia pisiformis, echinococcus granulosus , and removal and control of echincoccus multilocularis ). for removal of hookworms (ancylostoma caninum,uncinaria stenocephala ), ascarids (toxocara canis, toxascaris leonina ), and whipworms (trichuris vulpis ) in dogs. do not use in pregnant animals. dogs treated with elevated levels (6 consecutive days with 3 times the labeled dosage rate) of the combination of febantel and praziquantel in early pregnancy demonstrated an increased incidence of abortion and fetal abnormalities.8 the effects of drontal® plus on pregnant animals have not been determined. there are no known contraindications against the use of praziquantel or pyrantel pamoate in dogs.

Spojené státy - angličtina - NLM (National Library of Medicine)

bayer healthcare llc animal health division - praziquantel (unii: 6490c9u457) (praziquantel - unii:6490c9u457) - praziquantel 56.8 mg in 1 ml - droncit (praziquantel) injectable cestocide is indicated for the removal of the following canine and/or feline cestodes. dogs: dipylidium caninum, taenia pisiformis, echinococcus granulosus and for the removal and control of echinococcus multilocularis . cats: taenia taeniaeformis and dipylidium caninum . there are no known contraindications to the use of praziquantel.

Spojené státy - angličtina - NLM (National Library of Medicine)

bayer healthcare llc animal health division - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - cattle - single-dose therapy: baytril® 100 is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis in beef and non-lactating dairy cattle; and for the control of brd in beef and non-lactating dairy cattle at high risk of developing brd associated with m. haemolytica, p. multocida, h. somni and m. bovis. cattle - multiple-day therapy: baytril® 100 is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida and histophilus somni in beef and non-lactating dairy cattle. swine: baytril® 100 is indicated for the treatment and control of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, haemophilus parasuis, streptococcus suis, bordetella bronchiseptica and mycoplasma hyopneumoniae. baytril® 100 is indicated for the control of colibacillosis in groups or pens of weaned p

Spojené státy - angličtina - NLM (National Library of Medicine)

bayer healthcare, llc animal health division - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - baytril® 100-ca1 is indicated for the treatment of clinical anaplasmosis associated with anaplasma marginale in replacement dairy heifers under 20 months of age and all classes of beef cattle except beef calves less than 2 months of age and beef bulls intended for breeding (any age). not for use in any other class of dairy cattle or in veal calves.